Half Year 2026 Scancell Holdings PLC Earnings Call Transcript

Jan 29, 2026 / 02:00 PM GMT

Release Date Price: £0.13 (-2.80%)

Transcript

Key Points

Positve

Scancell Holdings PLC (SCNLF) has achieved FDA clearance for its phase 3 study of iSGB1 plus, marking a significant regulatory milestone.
The iSGB1 plus product has shown a progression-free survival rate of 74% at 16 months, which is a 24% improvement over historical data.
The company has a strong patent protection for iSGB1 plus extending to 2041, ensuring long-term market exclusivity.
Scancell Holdings PLC (SCNLF) has a robust pipeline with multiple assets, including Modi 1 in clinical trials and a promising antibody portfolio.
The company is exploring both independent and partnership strategies for commercialization, providing flexibility in its development approach.

Negative

Scancell Holdings PLC (SCNLF) reported no revenues for the period, indicating a reliance on future milestones and partnerships for financial growth.
The company recorded an operating loss of 8.9 million, highlighting ongoing financial challenges.
There is uncertainty regarding the timing and success of securing breakthrough designation and fast track status for iSGB1 plus.
The phase 3 trial for iSGB1 plus is double-blinded, meaning there will be limited data updates until the study concludes in 2029.
The company faces potential dilution risk as it explores financing options to support its development pipeline.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SCLP.L - Scancell Holdings PLC
Half Year 2026 Scancell Holdings PLC Earnings Call
Jan 29, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and good afternoon to all our listeners. Welcome to Scanell's results call for the six months ended 31st of October 2025.

My name is Marianne Chang, Invest relations.

And with us presenting today, we have our CEO Phil Willier and our CFO Seth Mira Nanaan.

After the presentation, we'll conduct a Q&A session for which you may submit written questions at any point during the webcast.

Before we start a few housekeeping items, this call is being recorded, and at this time all participants are in listen-only mode.

Please note today's discussion will include forward-looking statements which are based on current expectations and assumptions. Actual results may differ

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.